胺碘酮治疗急诊快速型心律失常患者的临床效果观察

Observation on the Clinical Effect of Amiodarone in the Treatment of Patients with Emergency Tachycardiac Arrhythmia

目的探讨胺碘酮治疗急诊快速型心律失常患者的临床效果。方法纳入我院2016年12月到2018年12月收治的急诊快速型心律失常患者86例,43例采用胺碘酮治疗者为研究组,43例采用利多卡因治疗者为参照组,比较两组的治疗效果。结果研究组治疗期间的心率、收缩压、舒张压、P-R间期、QT间期均显著优于参照组(P<0.05)。研究组的首转律成功率为58.14%、病死率为4.65%,均显著优于参照组的34.88%、13.95%(P<0.05)。研究组的不良反应发生率为37.21%,显著低于参照组的72.09%(P<0.05)。结论胺碘酮治疗急诊快速型心律失常安全有效,可改善患者的心率、血压以及心电图。

Objective To explore the clinical effect of amiodarone in treating patients with emergency tachycardiac arrhythmia.Methods 86 patients with emergency tachycardiac arrhythmia from December, 2016 to December, 2018 in our hospital were enrolled. 43 patients treated with amiodarone were set as study group, and 43 patients treated with lidocaine were set as control group. The curative effects of two groups were compared. Results During treatment, the heart rate, systolic blood pressure, diastolic blood pressure, P-R interval and QT interval of study group were significantly better than those of control group(P<0.05). The success rate of first cardioversion and mortality rate of study group was 58.14% and 4.65%, significantly better than 34.88% and 13.95% of control group(P<0.05). The incidence of adverse reactions of study group was 37.21%, significantly lower than 72.09% of control group(P<0.05). Conclusions Amiodarone is safe and effective in treatment of emergency tachycardiac arrhythmia, which can improve the heart rate, blood pressure and ECG of patients.